Mercer Global Advisors
EBS icon

Mercer Global Advisors’s Emergent Biosolutions EBS Stock Holding History

Mercer Global Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
26,419
+10,925
+71% +$91.4K ﹤0.01% 3142
2026
Q1 		$129K Buy
+15,494
New +$160K ﹤0.01% 2958

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Mercer Global Advisors's EBS Position: Q2 2026 in Review

Mercer Global Advisors increased its Emergent Biosolutions (EBS) stake by 71% in Q2 2026, buying an estimated $91.4K and bringing the position to 26,419 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #3142.

Mercer Global Advisors first reported a position in EBS in Q1 2026 and has held it in 2 quarters since. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Mercer Global Advisors held 26,419 shares of Emergent Biosolutions worth $221K as of Q2 2026.
  • Mercer Global Advisors bought 10,925 Emergent Biosolutions shares in Q2 2026, an estimated $91.4K.
  • Emergent Biosolutions made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3142 holding.
  • Mercer Global Advisors first reported a position in Emergent Biosolutions in Q1 2026 and has held it in 2 quarters since.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.